Avenue Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.76 USD | +3.58% | -6.00% | -68.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.86% | 3.42M | |
+8.57% | 114B | |
+10.55% | 104B | |
-12.71% | 22.41B | |
-0.32% | 22.28B | |
-5.75% | 19.07B | |
-37.36% | 18B | |
-5.68% | 17.89B | |
+6.98% | 14.28B | |
+36.59% | 12.55B |
- Stock Market
- Equities
- ATXI Stock
- News Avenue Therapeutics, Inc.
- Avenue Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt